Sonidegib

Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.[2] Sonidegib is Hedgehog signaling pathway inhibitor (via smoothened antagonism).[3][4] Contents 1 Approvals and indications 2 Pharmacology 3 Development 4 References 5 External links Approvals and indications It was approved for medical use in the United States and in the European Union in 2015[5][6][7]... [wikipedia]